
GeneMedicine
Developer of oncology therapeutic medicines designed to treat intractable cancers. The company's medicines utilize novel and innovative adenoviral vector platforms, which can selectively lyse cancer c...
Valuation
$0
Share Price
N/A
Total Raised
$45.3M
Last Round
N/A